According to BioLineRx's latest financial reports the company's current EPS (TTM) is -$1.50. In 2022 the company made an earnings per share (EPS) of -$0.75 an increase over its 2021 EPS that were of -$1.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.50 | 99.37% |
2022 | -$0.75 | -25% |
2021 | -$1.00 | -66.67% |
2020 | -$3.00 | -29.41% |
2019 | -$4.25 | -19.05% |
2018 | -$5.25 | -22.22% |
2017 | -$6.75 | -3.57% |
2016 | -$7.00 | -0% |
2015 | -$7.00 | -17.65% |
2014 | -$8.50 | -55.26% |
2013 | -$19.00 | -36.9% |
2012 | -$30.12 | 11.81% |
2011 | -$26.93 | -737.01% |
2010 | $4.23 |